title: Confirmation of mendelian properties of heterodimeric fibrinogen molecules in a heterozygotic dysfibrinogenemia, "fibrinogen Amarillo," using gprphoresis to differentiate semifibrin molecules from fibrinogen and fibrin.
abstract: The fibrinogen molecule consists of two sets of Aalpha, Bbeta, and gamma chains assembled into a bilateral disulfide linked (Aalpha, Bbeta, gamma)2 structure. Cleavage of the two A-fibrinopeptides (FPA, Aalpha1-16) from normal Aalpha chains with arginine at position 16 (RFPA) by thrombin or the venom enzyme atroxin transforms fibrinogen into self-aggregating fibrin monomers (alpha, Bbeta, gamma)(2). Mutant Aalpha16R-->H fibrinopeptide (HFPA) cannot be cleaved from fibrinogen by atroxin. Many studies on heterozygous dysfibrinogenemias with this mutation suggested that incorporation of the mutant chains into the molecules was ordered in a manner yielding only (1) homodimeric normal (RFPARFPA) atroxin-coagulable molecules and (2) homodimeric abnormal (H(FPA)HFPA) atroxin-incoagulable molecules in equal quantities. Although heterodimeric molecules (RFPAHFPA) could not be found in studies on the intact protein, Meh et al. demonstrated their existence by showing that CNBr digests of fibrinogens from atroxin-treated Aalpha16R-->H heterozygotic dysfibrinogenemias consistently yielded N-terminal fragments (NDSKs) with partially resolved electrophoretic bands predominantly in between the NDSKs of fibrinogen and alpha-fibrin. An opportunity to confirm and better quantify the heterodimers arose with the recent development of a method (GPRphoresis) for identifying molecules lacking only one FPA, which is applied here in study of a newly presenting case of an Aalpha16R-->H dysfibrinogenemia, "fibrinogen Amarillo." GPRphoresis uses electrophoretic shifts, staged with GPRP-NH(2) to separate the self-aggregating fibrin monomers lacking both FPAs from weakly aggregating "semifibrin" molecules lacking one FPA An antifibrin alpha17-23 antibody is used to measure and differentiate the semifibrin from fibrinogen with FPA fully intact. Applying GPRphoresis to atroxin digests of fibrinogen Amarillo clearly demonstrated RFPARFPA, RFPAHFPA, and HFPAHFPA molecules in nearly perfect Mendelian 1:2:1 proportions. In turn, the high levels of the semifibrin in the terminal atroxin digests provide genetic phenotypic evidence supporting fidelity of the GPRphoresis method.
authors.affiliation: Department of Chemistry Cleveland State University, 2351 Euclid Avenue, Cleveland, OH 44115-2406, USA. j.shainoff@csuohio.edu
authors.forename: J R
authors.initials: JR
authors.lastname: Shainoff
authors.forename: O D
authors.initials: OD
authors.lastname: Ratnoff
authors.forename: G B
authors.initials: GB
authors.lastname: Smejkal
authors.forename: P M
authors.initials: PM
authors.lastname: DiBello
authors.forename: W R
authors.initials: WR
authors.lastname: Welches
authors.forename: H
authors.initials: H
authors.lastname: Lill
authors.forename: O V
authors.initials: OV
authors.lastname: Mitkevich
authors.forename: P
authors.initials: P
authors.lastname: Periman
mesh_terms: D019281:Dimerization; D004591:Electrophoresis, Polyacrylamide Gel; D005192:Family Health; D005337:Fibrin / Q000378:metabolism; D015241:Fibrinogens, Abnormal / Q000235:genetics* / Q000378:metabolism; D005344:Fibrinopeptide A / Q000378:metabolism; D006579:Heterozygote; D006801:Humans; D007700:Kinetics; D017354:Point Mutation; D012697:Serine Endopeptidases / Q000378:metabolism
chemical_list: D015241:Fibrinogens, Abnormal; D005344:Fibrinopeptide A; D005337:Fibrin; D012697:Serine Endopeptidases; C092615:atroxin